Suppr超能文献

DNA 甲基化通过两个 5' 启动子 CpG 位点调节自然杀伤细胞中的 Siglec-7。

DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.

机构信息

Department of Biotechnology and Laboratory Science in Medicine, School of Biomedical Science and Engineering, National Yang-Ming University, Taipei, Taiwan.

Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan.

出版信息

Immunology. 2020 May;160(1):38-51. doi: 10.1111/imm.13179. Epub 2020 Mar 5.

Abstract

First discovered on the natural killer (NK) cell, the cell surface inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) is known for regulating many important biological activities. However, the detail regulatory mechanism for Siglec-7 expression in NK cells currently remains unclear. In this study, we aimed to investigate how cell surface Siglec-7 expression is regulated and found that, in both NK cell lines and peripheral NK cells, transcription was the main regulatory step. Furthermore, when NK-92MI and peripheral NK cells were treated with DNA methyltransferase (DNMT) inhibitor, the CpG island, with 9 CpG sites, in 5' Siglec-7 promoter became noticeably hypomethylated, and Siglec-7 expression increased in both RNA transcript and surface protein. Within this CpG island, we identified both CpG 8 and CpG 9 as two key regulators responsible for Siglec-7 expression. Additionally, by using histone deacetylases (HDAC) inhibitor, butyric acid, we showed that Siglec-7 expression was also subjected to the histone modification. And a combined treatment with both 5-azacytidine and butyric acid showed an additive effect on Siglec-7 transcript expression in peripheral NK cells.

摘要

首先在自然杀伤 (NK) 细胞上发现的细胞表面抑制性受体唾液酸结合免疫球蛋白样凝集素-7(Siglec-7),其特征在于调节许多重要的生物学活性。然而,Siglec-7 在 NK 细胞中的表达的详细调节机制目前尚不清楚。在这项研究中,我们旨在研究细胞表面 Siglec-7 表达是如何被调节的,并发现无论是在 NK 细胞系还是外周 NK 细胞中,转录都是主要的调节步骤。此外,当 NK-92MI 和外周 NK 细胞用 DNA 甲基转移酶 (DNMT) 抑制剂处理时,在 5' Siglec-7 启动子中带有 9 个 CpG 位点的 CpG 岛明显去甲基化,RNA 转录物和表面蛋白中的 Siglec-7 表达均增加。在这个 CpG 岛内,我们确定了 CpG 8 和 CpG 9 作为两个负责 Siglec-7 表达的关键调节因子。此外,通过使用组蛋白去乙酰化酶 (HDAC) 抑制剂丁酸,我们表明 Siglec-7 表达也受到组蛋白修饰的影响。并且 5-氮杂胞苷和丁酸的联合处理在外周 NK 细胞中对 Siglec-7 转录物表达表现出相加作用。

相似文献

1
DNA methylation-mediated Siglec-7 regulation in natural killer cells via two 5' promoter CpG sites.
Immunology. 2020 May;160(1):38-51. doi: 10.1111/imm.13179. Epub 2020 Mar 5.
2
Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Immunol Res. 2017 Oct;65(5):1017-1024. doi: 10.1007/s12026-017-8942-y.
3
Reduced Siglec-7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma.
Clin Exp Immunol. 2020 Aug;201(2):161-170. doi: 10.1111/cei.13444. Epub 2020 May 17.
6
Identification and functional characterization of a Siglec-7 counter-receptor on K562 cells.
J Biol Chem. 2021 Jan-Jun;296:100477. doi: 10.1016/j.jbc.2021.100477. Epub 2021 Feb 26.
8
Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells.
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10410-10415. doi: 10.1073/pnas.1804108115. Epub 2018 Sep 25.
9
Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
Biochim Biophys Acta. 2013 Dec;1833(12):2970-2979. doi: 10.1016/j.bbamcr.2013.08.001. Epub 2013 Aug 13.

引用本文的文献

2
The epigenetic hallmarks of immune cells in cancer.
Mol Cancer. 2025 Mar 5;24(1):66. doi: 10.1186/s12943-025-02255-4.
4
Epigenetic regulation and therapeutic targets in the tumor microenvironment.
Mol Biomed. 2023 Jun 5;4(1):17. doi: 10.1186/s43556-023-00126-2.
5
Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.
Front Immunol. 2021 Jul 1;12:694055. doi: 10.3389/fimmu.2021.694055. eCollection 2021.
6
Sialic Acids and Their Influence on Human NK Cell Function.
Cells. 2021 Jan 29;10(2):263. doi: 10.3390/cells10020263.

本文引用的文献

1
Siglec-7 on peripheral blood eosinophils: Surface expression and function.
Allergy. 2019 Jul;74(7):1257-1265. doi: 10.1111/all.13730. Epub 2019 Feb 26.
2
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan.
Clin Cancer Res. 2018 Dec 15;24(24):6160-6167. doi: 10.1158/1078-0432.CCR-18-0421. Epub 2018 Aug 10.
4
Epigenetic therapy: azacytidine and decitabine in acute myeloid leukemia.
Expert Rev Hematol. 2018 May;11(5):361-371. doi: 10.1080/17474086.2018.1453802. Epub 2018 Mar 27.
5
Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Immunol Res. 2017 Oct;65(5):1017-1024. doi: 10.1007/s12026-017-8942-y.
7
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
8
From profiles to function in epigenomics.
Nat Rev Genet. 2017 Jan;18(1):51-66. doi: 10.1038/nrg.2016.138. Epub 2016 Nov 21.
10
Natural Killer Cells--An Epigenetic Perspective of Development and Regulation.
Int J Mol Sci. 2016 Mar 1;17(3):326. doi: 10.3390/ijms17030326.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验